Douglas Yee MD
Breast Cancer, Hematologic Oncology
Professor of Medicine Director, Masonic Cancer Center, University of Minnesota
Join to View Full Profile
Masonic Cancer Center, University of Minnesota420 Delaware Street SEMinneapolis, MN 55455
Phone+1 612-626-8487
Dr. Yee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
University of North Carolina HospitalsResidency, Internal Medicine, 1981 - 1985
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1981
Certifications & Licensure
MN State Medical License 1999 - 2026
TX State Medical License 1989 - 2007
NC State Medical License 1984 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer Start of enrollment: 2006 Jul 01
- CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
- Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca Start of enrollment: 2008 Sep 01
Publications & Presentations
PubMed
- RISE UP for breast cancer 2024: conference highlights & takeaways.Taylor Glatt, Katherine Leggat-Barr, Nandini Seth, Diane Heditsian, Laura van 't Veer
Breast Cancer Research and Treatment. 2026-01-06 - 1 citationsEnhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.Hans Wildiers, Virginie Adam, Seamus O'Reilly, Josephine Van Cauwenberge, Amal Arahmani
JAMA Oncology. 2025-12-18 - mRNA and Protein Expression of Fetal Insulin Receptor in Breast Cancer Cell Lines.Xihong Zhang, Albert Barrios, LeeAnn Higgins, Todd Markowski, Kevin Murray
Biorxiv. 2025-12-17
Lectures
- The DNA Cytosine Deaminase APOBEC3B Promotes Tamoxifen Resistance in ER-Positive Breast CancerAmerican Society of Clinical Oncology(ASCO), Chicago, Illinois - 8/9/2013
- The DNA Cytosine Deaminase APOBEC3B Promotes Tamoxifen Resistance in ER-Positive Breast CancerAmerican Society of Clinical Oncology(ASCO), Los Angeles, California - 8/16/2013
Press Mentions
Meet the Group Making Cancer Trials More Equitable in MinnesotaNovember 13th, 2024- What Black Women Should Know on Metastatic Breast Cancer Awareness DayOctober 16th, 2024
- What Black Women Should Know About Metastatic Breast CancerOctober 14th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
